Assessment of monoamine transporter inhibition in the mediation of cocaine-induced conditioned taste aversion
Introduction
Cocaine, like a number of other drugs of abuse, has been shown to possess both rewarding (Nomikos and Spyraki, 1988, Wise et al., 1992) and aversive (Ettenberg, 2004, Ferrari et al., 1991, Koob et al., 1997) properties. Although its rewarding effects appear to be mediated by monoamine transporter inhibition in the central nervous system (CNS; Ritz et al., 1987, Rocha, 2003), the basis for the aversive effects of cocaine is less well understood. Interest in the aversive properties of abused drugs stems from the notion that the acceptability and abuse potential of the drug may depend on a balance of its rewarding and aversive effects (Riley and Simpson, 2001). Understanding the physiological bases of cocaine's aversive effects as well as the conditions under which they occur may provide insight into a key vulnerability factor mediating the abuse potential of cocaine.
In the investigation of cocaine's behavioral effects, one area that has received considerable attention is its action on monoaminergic systems. Cocaine affects monoamine activity by acting as an indirect agonist for the three monoamine neurotransmitters dopamine (DA), norepinephrine (NE) and serotonin (5-HT) via its blockade of their respective transporter proteins (Taylor and Ho, 1978, Woolverton and Johnson, 1992). To understand the relative roles of cocaine's actions on each of these monoamine systems in the expression of various behaviors (e.g., self-administration [SA], drug discrimination [DD]), researchers have employed pharmacological probes that act with relative specificity on each of the monoamine transporters and have compared the effects of these drugs to those of cocaine (Baker et al., 1993, Cunningham and Callahan, 1991, Tella, 1995). Although these assessments have provided insight into the rewarding (Tella, 1995) and discriminative stimulus (Baker et al., 1993, Cunningham and Callahan, 1991) effects of cocaine, this methodology has yet to be used to examine cocaine's aversive effects. There is some evidence that 5-HT transporter (SERT) inhibition with fluoxetine can induce a CTA (Berendsen and Broekkamp, 1994, Prendergrast et al., 1996), although no comparison was made to cocaine in these assessments. In addition, there appears to be a dopaminergic contribution to cocaine-induced CTAs as the DA receptor antagonist pimozide has been shown to attenuate a cocaine-induced CTA (Hunt et al., 1985). However, this demonstration did not assess the direct effect of DA transporter (DAT) inhibition on the induction of a CTA.
Recent work examining factors outside of cocaine's monoaminergic activity highlight the possibility that monoamine transporter inhibition may be mediating its aversive effects. Specifically, a report by Freeman et al. (2005) comparing the aversive effects of cocaine to the analogs procaine and cocaine methiodide in the conditioned taste aversion (CTA) preparation demonstrated that the full expression of cocaine's aversive effects do not appear to be singularly mediated by either sodium channel inhibition or activity in the peripheral nervous system (PNS). That is, neither the inhibition of sodium channels with procaine nor the cocaine-like actions in the PNS induced by peripherally administered cocaine methiodide produced aversions comparable in magnitude to cocaine when matched by dose, although each analog did induce some degree of aversion by itself. Given that neither of these compounds specifically allowed for an assessment of the contribution of monoamine transporter inhibition, there remains the possibility that one or more of the monoamine systems may be participating in the mediation of cocaine's aversive effects.
In order to make a systematic assessment of monoamine transport inhibition as a mediator of cocaine-induced CTA, the present study compared cocaine to three reuptake inhibitors, each of which possesses relative specificity for one of the three monoamine transporters, in their ability to induce a CTA. Specifically, rats were given access to a novel saccharin solution and injected with either cocaine, GBR 12909 (DAT inhibitor; Andersen, 1989), desipramine (NE transporter [NET] inhibitor; Tatsumi et al., 1997) or clomipramine (SERT inhibitor; Thomas and Jones, 1977) at one of three doses (18, 32 and 50 mg/kg).
Section snippets
Subjects
The subjects were 104 male Sprague–Dawley rats, approximately 150 days of age and 300–400 g at the beginning of the experiment. The specific study described was approved by the Institutional Animal Care and Use Committee at American University and was conducted under the procedures recommended by the Guide for the Care and Use of Laboratory Animals (National Research Council, 1996) and the Guidelines for the Care and Use of Mammals in Neuroscience and Behavioral Research (National Research
Results
A 13 × 5 Repeated Measures ANOVA revealed significant main effects for Group (F(12,91) = 23.898, p ≤ .0001) and Trial (F(4,364) = 81.315, p ≤ .0001) as well as a significant Group × Trial interaction (F(48,364) = 9.573, p ≤ .0001). On Trial 1, a one-way ANOVA revealed no significant main effect for Group (F(12,91) = .103, p ≥ .9999). However, subsequent one-way ANOVAs conducted on Trials 2–4 and on the Final Aversion Test revealed significant main effects for Group (all F's(12,91) ≥ 10.913, all p's ≤ .0001).
Fig. 1
Discussion
Cocaine acts as an indirect agonist on the three monoamine neurotransmitter systems (DA, NE and 5-HT) by binding to their cognate transporter proteins. Although the rewarding and discriminative stimulus properties of cocaine appear to be mediated largely by the dopaminergic system (Baker et al., 1993, Cunningham and Callahan, 1991, Kleven et al., 1990, Tella, 1995), it is unclear to what extent cocaine's actions on these three monoamine systems participate in its aversive effects. To assess
Acknowledgement
This research was supported by a grant from the Mellon Foundation to A.L.R. Requests for reprints should be directed to Kevin B. Freeman, Psychopharmacology Laboratory, Department of Psychology, American University, Washington, DC 20016 or [email protected].
References (40)
The dopamine uptake inhibitor GBR12909: selectivity and molecular mechanism of action
Eur J Pharmacol
(1989)- et al.
Comparison of stimulus properties of fluoxetine and 5-HT receptor agonists in a conditioned taste aversion procedure
Eur J Pharmacol
(1994) - et al.
The interaction of sex and route of drug administration in cocaine-induced conditioned taste aversions
Pharmacol Biochem Behav
(2005) Opponent process properties of self-administered cocaine
Neurosci Biobehav Rev
(2004)- et al.
Cocaine-induced taste aversions: effect of route of administration
Pharmacol Biochem Behav
(1991) - et al.
Relative hedonic value modulates anticipatory contrast
Physiol Behav
(1994) - et al.
Assessment of the contributions of Na+ channel inhibition and general peripheral action in cocaine-induced conditioned taste aversion
Pharmacol Biochem Behav
(2005) - et al.
Involvement of dopamine in the aversive stimulus properties of cocaine in rats
Pharmacol Biochem Behav
(1985) - et al.
Opponent process model of psychostimulant addiction
Pharmacol Biochem Behav
(1997) - et al.
Cocaine-induced hypertension: role of the peripheral sympathetic system
Pharmacol Res
(1999)
Stimulant and reinforcing effects of cocaine in monoamine transporter knockout mice
Eur J Pharmacol
GBR 12909 antagonizes the ability of cocaine to elevate extracellular levels of dopamine
Pharmacol Biochem Behav
Pharmacological mechanisms in cocaine's cardiovascular effects
Drug Alcohol Depend
Intravenous cocaine increases plasma epinephrine and norepinephrine in humans
Pharmacol Biochem Behav
Pharmacological profile of antidepressants and related compounds at human monoamine transporters
Eur J Pharmacol
Effects of monoamine reuptake inhibitors on cocaine self-administration in rats
Pharmacol Biochem Behav
Evaluation of the reinforcing effects of atomoxetine in monkeys: comparison to methylphenidate and desipramine
Drug Alcohol Depend
Evaluation of the role of norepinephrine in the reinforcing effects of psychomotor stimulants in rhesus monkeys
Pharmacol Biochem Behav
Neurobiology of cocaine abuse
Trends Pharmacol Sci
Biochemical and pharmacological characterization of [3H]GBR 12935 binding in vitro to rat striatal membranes: labeling of the dopamine uptake complex
J Neurochem
Cited by (16)
Abuse potential and toxicity of the synthetic cathinones (i.e., “Bath salts”)
2020, Neuroscience and Biobehavioral ReviewsConditioned taste avoidance induced by the combination of heroin and cocaine: Implications for the use of speedball
2019, Pharmacology Biochemistry and BehaviorCitation Excerpt :The second letter/number refers to an injection of either vehicle (V) or cocaine (10, 18 or 32 mg/kg). The specific doses of heroin and cocaine used (as well as their specific routes of administration) were based on prior work reporting minimal to weak (heroin: Davis et al., 2009) and dose-related (cocaine: Freeman et al., 2005) taste avoidance. The mixed model ANOVA on saccharin consumption revealed a significant effect of Drug [F(7,56) = 12.893, p < .0001], Trial [F(4,224) = 62.702, p < .0001] and a significant Drug × Trial interaction [F(28,224) = 12.581, p < .0001].
Conditioned taste avoidance, conditioned place preference and hyperthermia induced by the second generation ‘bath salt’ α-pyrrolidinopentiophenone (α-PVP)
2017, Pharmacology Biochemistry and BehaviorCitation Excerpt :The limited work with cocaine suggests that dopamine activity may mediate, in part, its aversive effects. For example, a variety of dopamine antagonists block cocaine-induced taste avoidance (Freeman et al., 2005b; Hunt et al., 1985; Serafine et al., 2011, 2012) and cocaine's aversive effects are significantly attenuated by a prior history with other dopamine-reuptake inhibitors, an effect generally interpreted to be a function of cross-tolerance between the compounds (Berman and Cannon, 1974; Freeman et al., 2005b; LeBlanc and Cappell, 1974; Serafine and Riley, 2010; for a review, see Riley and Simpson, 2001). It is interesting in this context that MDPV appears to be roughly 10 times more potent than cocaine in inducing taste avoidance (Freeman et al., 2005a, b; King et al., 2014, 2015; Marusich et al., 2014; Merluzzi et al., 2013; Serafine et al., 2012; Woloshchuk et al., 2016).
Cocaine facilitates glutamatergic transmission and activates lateral habenular neurons
2013, NeuropharmacologyThe effects of the 5-HT<inf>3</inf> receptor antagonist tropisetron on cocaine-induced conditioned taste aversions
2013, Pharmacology Biochemistry and BehaviorCitation Excerpt :The first letter in each group designation refers to the pretreatment drug (Tropisetron, T, or Vehicle, V); the number refers to the dose of cocaine given during conditioning. The specific doses of cocaine used in this assessment were based on previous work reporting the ability of these doses to produce graded aversions that ranged from little to intermediate to near complete suppression (see Ferrari et al., 1991; Freeman et al., 2005). Such a dose range provides behavioral effects that are subject to modulation and allows for attenuation or potentiation of aversions to be seen.
Dopamine mediates cocaine-induced conditioned taste aversions as demonstrated with cross-drug preexposure to GBR 12909
2012, Pharmacology Biochemistry and Behavior